WIRED @WIRED
The promise of mRNA technology was its adaptability—vaccine makers touted its plug-and-play nature. So why haven’t variant-specific boosters arrived sooner? Read all about the state of mRNA tech and the challenges ahead: https://t.co/w5jK42C8mv 🎨: Jacqui Vanliew https://t.co/KjFzsi4U1k — PolitiTweet.org